Skip to main content

Advertisement

Log in

Mixed Esophageal Disease (MED): A New Concept

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

A Concise Commentary to this article was published on 25 July 2023

Abstract

We define mixed esophageal disease (MED) as a disorder of esophageal structure and/or function that produces variable signs or symptoms, simulating-fully or in part other well-defined esophageal conditions, such as gastroesophageal reflux disease, esophageal motility disorders, or even neoplasia. The central premise of the MED concept is that of an overlap syndrome that incorporates selected clinical, endoscopic, imaging, and functional features that alter the patient’s quality of life and affect natural history, prognosis, and management. In this article, we highlight MED scenarios frequently encountered in medico-surgical practices worldwide, posing new diagnostic and therapeutic challenges. These, in turn, emphasize the need for better understanding and management, aiming towards improved outcomes and prognosis. Since MED has variable and sometimes time-evolving clinical phenotypes, it deserves proper recognition, definition, and collaborative, multidisciplinary approach, be it pharmacologic, endoscopic, or surgical, to optimize therapeutic outcomes, while minimizing iatrogenic complications. In this regard, it is best to define MED early in the process, preferably by teams of clinicians with expertise in managing esophageal diseases. MED is complex enough that is increasingly becoming the subject of virtual, multi-disciplinary, multi-institutional meetings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA 2020;324:2536–2547. https://doi.org/10.1001/jama.2020.21360.

    Article  CAS  PubMed  Google Scholar 

  2. Patel DA, Yadlapati R, Vaezi MF. Esophageal motility disorders: current approach to diagnostics and therapeutics. Gastroenterology 2022;162:1617–1634. https://doi.org/10.1053/j.gastro.2021.12.289.

    Article  CAS  PubMed  Google Scholar 

  3. Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009;54:2312–2317. https://doi.org/10.1007/s10620-009-0951-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Triadafilopoulos G, Clarke JO, Hawn M. Precision GERD management for the 21st century. Dis Esophagus 2017;30:1–6. https://doi.org/10.1093/dote/dox079.

    Article  PubMed  Google Scholar 

  5. Ravi K, Ramchandani M. POEM and GERD: prevalence, mechanisms, potential strategies for prevention, and management. Clin Gastroenterol Hepatol 2022;20:2444–2447. https://doi.org/10.1016/j.cgh.2022.05.040.

    Article  PubMed  Google Scholar 

  6. Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus 2013;26:443–450. https://doi.org/10.1111/j.1442-2050.2012.01381.x.

    Article  CAS  PubMed  Google Scholar 

  7. Kamal AN, Triadafilopoulos G, Gyawali CP et al. Model for multi-disciplinary, multi-institutional virtual learning: the Stanford Esophageal Virtual Collaborative Conference on benign esophageal diseases. Neurogastroenterol Motil 2022;34:e14369.

    Article  PubMed  Google Scholar 

  8. Howden CW, Manuel M, Taylor D, Jariwala-Parikh K, Tkacz J. Estimate of refractory reflux disease in the united states: economic burden and associated clinical characteristics. J Clin Gastroenterol 2021;55:842–850. https://doi.org/10.1097/MCG.0000000000001518.

    Article  PubMed  Google Scholar 

  9. Yadlapati R, Gyawali CP, Pandolfino JE, CGIT GERD Consensus Conference Participants. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 2022;20:984-994.e1. https://doi.org/10.1016/j.cgh.2022.01.025. (Erratum in: Clin Gastroenterol Hepatol. 2022 Sep;20:2156).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Patients with Barrett’s esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls. Neurogastroenterol Motil 2017;29 (4). https://pubmed.ncbi.nlm.nih.gov/27891754/

  11. Fass R, Teramoto O, Kurin M, Khalessi A, Kitayama Y, Shibli F. Esophageal function abnormalities in patients with Barrett’s esophagus. J Clin Gastroenterol 2020;54:485–492.

    Article  CAS  PubMed  Google Scholar 

  12. Yadlapati R, Triggs J, Quader F et al. Reduced esophageal contractility is associated with dysplasia progression in Barrett’s esophagus: a multicenter cohort study. Dig Dis Sci 2020;65:3631–3638.

    Article  CAS  PubMed  Google Scholar 

  13. Triadafilopoulos G, Friedland S. Precision care for Barrett’s esophagus. Transl Gastroenterol Hepatol 2018;3:67. https://doi.org/10.21037/tgh.2018.09.10.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chang NC, Thakkar KP, Ketchem CJ, Eluri S, Reed CC, Dellon ES. A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients. Clin Gastroenterol Hepatol 2022;20:1701-1708.e2. https://doi.org/10.1016/j.cgh.2021.10.028.

    Article  PubMed  Google Scholar 

  15. Aceves SS, Alexander JA, Baron TH et al. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc 2022;96:576-592.e1. https://doi.org/10.1016/j.gie.2022.05.013.

    Article  PubMed  Google Scholar 

  16. Hirano I, Dellon ES, Hamilton JD et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology 2020;158:111-122.e10. https://doi.org/10.1053/j.gastro.2019.09.042.

    Article  CAS  PubMed  Google Scholar 

  17. Stoschus B, Allescher HD. Drug-induced dysphagia. Dysphagia 1993;8:154–159. https://doi.org/10.1007/BF02266997.

    Article  CAS  PubMed  Google Scholar 

  18. Castell DO. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1991;5 Suppl 1:59–67. https://doi.org/10.1111/j.1365-2036.1991.tb00749.x.

    Article  CAS  PubMed  Google Scholar 

  19. Hoversten P, Otaki F, Katzka DA. Course of esophageal candidiasis and outcomes of patients at a single center. Clin Gastroenterol Hepatol 2019;17:200-202.e1. https://doi.org/10.1016/j.cgh.2018.04.035.

    Article  PubMed  Google Scholar 

  20. Roman S, Kahrilas PJ. Management of spastic disorders of the esophagus. Gastroenterol Clin North Am 2013;42:27–43. https://doi.org/10.1016/j.gtc.2012.11.002.

    Article  PubMed Central  Google Scholar 

  21. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001;281:G743–G751. https://doi.org/10.1152/ajpgi.2001.281.3.G743.

    Article  CAS  PubMed  Google Scholar 

  22. Campo S, Traube M. Manometric characteristics in idiopathic and reflux-associated esophageal spasm. Am J Gastroenterol 1992;87:187–189.

    CAS  PubMed  Google Scholar 

  23. Hong SN, Rhee PL, Kim JH et al. Does this patient have oesophageal motility abnormality or pathological acid reflux? Dig Liver Dis 2005;37:475–484. https://doi.org/10.1016/j.dld.2005.01.018.

    Article  CAS  PubMed  Google Scholar 

  24. Fass R, Mackel C, Sampliner RE. 24-Hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. J Clin Gastroenterol 1994;19:97–99.

    Article  CAS  PubMed  Google Scholar 

  25. Wong I, Law S. Peroral endoscopic myotomy (POEM) for treating esophageal motility disorders. Ann Transl Med 2017;5:192. https://doi.org/10.21037/atm.2017.04.36.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Savarino E, Bhatia S, Roman S et al. Achalasia. Nat Rev Dis Prim 2022;8:28. https://doi.org/10.1038/s41572-022-00356-8.

    Article  PubMed  Google Scholar 

  27. Repici A, Fuccio L, Maselli R et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018;87:934-943.e18.

    Article  PubMed  Google Scholar 

  28. Sato H, Nishikawa Y, Abe H et al. Esophageal carcinoma in achalasia patients managed with endoscopic submucosal dissection and peroral endoscopic myotomy: Japan Achalasia Multicenter Study. Dig Endosc. 2021. https://doi.org/10.1111/den.14197.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schizas D, Theochari NA, Katsaros I et al. Pseudoachalasia: a systematic review of the literature. Esophagus 2020;17:216–222. https://doi.org/10.1007/s10388-020-00720-1.

    Article  PubMed  Google Scholar 

  30. Gyawali CP, Sifrim D, Carlson DA et al. Ineffective esophageal motility: concepts, future directions, and conclusions from the Stanford 2018 symposium. Neurogastroenterol Motil 2019;31:e13584. https://doi.org/10.1111/nmo.13584.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Shetler KP, Bikhtii S, Triadafilopoulos G. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure. Dis Esophagus 2017;6:1–8. https://doi.org/10.1093/dote/dox012.

    Article  Google Scholar 

  32. Samo S, Qayed E. Esophagogastric junction outflow obstruction: where are we now in diagnosis and management? World J Gastroenterol 2019;25:411–417. https://doi.org/10.3748/wjg.v25.i4.411.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kahrilas PJ, Bredenoord AJ, Fox M et al. International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes. Nat Rev Gastroenterol Hepatol 2017;14:677–688.

    Article  Google Scholar 

  34. Ukegjini K, Vetter D, Fehr R, Dirr V, Gubler C, Gutschow CA. Functional syndromes and symptom-orientated aftercare after esophagectomy. Langenbecks Arch Surg 2021;406:2249–2261.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Lin DC, Chun CL, Triadafilopoulos G. Evaluation and management of patients with symptoms after anti-reflux surgery. Dis Esophagus 2015;28:1–10. https://doi.org/10.1111/dote.12103.

    Article  PubMed  Google Scholar 

  36. Westcott CJ, O’Connor S, Preiss JE, Patti MG, Farrell TM. Myotomy-first approach to epiphrenic esophageal diverticula. J Laparoendosc Adv Surg Tech A 2019;29:726–729. https://doi.org/10.1089/lap.2019.0239.

    Article  PubMed  Google Scholar 

  37. Ali AB, Khan NA, Nguyen DT et al. Robotic and per-oral endoscopic myotomy have fewer technical complications compared to laparoscopic Heller myotomy. Surg Endosc. 2020;34:3191–3196. https://doi.org/10.1007/s00464-019-07093-2.

    Article  PubMed  Google Scholar 

  38. Jadcherla AV, Litzenberg K, Balasubramanian G. Esophageal dysfunction in post-lung transplant: an enigma. Dysphagia. 2022. https://doi.org/10.1007/s00455-022-10508-3.

    Article  PubMed  Google Scholar 

  39. Hathorn KE, Chan WW, Lo WK. Role of gastroesophageal reflux disease in lung transplantation. World J Transplant 2017;7:103–116. https://doi.org/10.5500/wjt.v7.i2.103.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Castor JM, Wood RK, Muir AJ, Palmer SM, Shimpi RA. Gastroesophageal reflux and altered motility in lung transplant rejection. Neurogastroenterol Motil 2010;22:841–850. https://doi.org/10.1111/j.1365-2982.2010.01522.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Nguyen AD. Impact of bariatric surgery on gastroesophageal reflux disease and esophageal motility. Curr Opin Gastroenterol 2021;37:364–371. https://doi.org/10.1097/MOG.0000000000000745.

    Article  CAS  PubMed  Google Scholar 

  42. Mattar SG, Qureshi F, Taylor D, Schauer PR. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 2006;20:850–854. https://doi.org/10.1007/s00464-006-0513-6.

    Article  CAS  PubMed  Google Scholar 

  43. Jaruvongvanich V, Matar R, Ravi K et al. Esophageal pathophysiologic changes and adenocarcinoma after bariatric surgery: a systematic review and meta-analysis. Clin Transl Gastroenterol 2020;11:e00225. https://doi.org/10.14309/ctg.0000000000000225.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Triadafilopoulos G, Hallstone A, Nelson-Abbott H et al. Oropharyngeal and esophageal interrelationships in patients with nonobstructive dysphagia. Dig Dis Sci 1992;37:551–557.

    Article  CAS  PubMed  Google Scholar 

  45. Okwara NC, Chan WW. Sorting out the relationship between esophageal and pulmonary disease. Gastroenterol Clin N Am 2021;50:919–934. https://doi.org/10.1016/j.gtc.2021.08.006.

    Article  Google Scholar 

  46. Roman S, Kahrilas PJ. Mechanisms of Barrett’s oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects. Best Pract Res Clin Gastroenterol 2015;29:17–28. https://doi.org/10.1016/j.bpg.2014.11.002.

    Article  PubMed  Google Scholar 

  47. Andrici J, Tio M, Cox MR et al. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol 2013;28:415–431. https://doi.org/10.1111/j.1440-1746.2012.07199.x.

    Article  PubMed  Google Scholar 

  48. Yasuda K, Choi SE, Nishioka NS et al. Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett’s esophagus. Dig Dis Sci 2014;59:1560–1566. https://doi.org/10.1007/s10620-013-3002-5.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Baiu I, Lau J. What is a paraesophageal hernia? JAMA 2019;322:2146. https://doi.org/10.1001/jama.2019.17395.

    Article  PubMed  Google Scholar 

  50. Zikos TA, Clarke JO, Triadafilopoulos G et al. A positive correlation between gastric and esophageal dysmotility suggests common causality. Dig Dis Sci 2018;63:3417–3424. https://doi.org/10.1007/s10620-018-5175-4.

    Article  PubMed  Google Scholar 

  51. Su A, Gandhy R, Barlow C, Triadafilopoulos G. Clinical and manometric characteristics of patients with Parkinson’s disease and esophageal symptoms. Dis Esophagus 2017;30:1–6. https://doi.org/10.1093/dote/dow038.

    Article  CAS  PubMed  Google Scholar 

  52. Fitzgerald RC, Triadafilopoulos G. Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum 1997;26:641–666. https://doi.org/10.1016/s0049-0172(97)80001-7.

    Article  CAS  PubMed  Google Scholar 

  53. Ahuja NK, Clarke JO. Scleroderma and the esophagus. Gastroenterol Clin N Am 2021;50:905–918. https://doi.org/10.1016/j.gtc.2021.08.005.

    Article  Google Scholar 

  54. Miele CH, Schwab K, Saggar R et al. Lung transplant outcomes in systemic sclerosis with significant esophageal dysfunction. A comprehensive single-center experience. Ann Am Thorac Soc 2016;13:793–802. https://doi.org/10.1513/AnnalsATS.201512-806OC.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Greenberg JA, Palacardo F, Edelmuth RCL et al. Comparative outcomes of anti-reflux surgery in obese patients with gastroesophageal reflux disease. J Gastrointest Surg. 2022. https://doi.org/10.1007/s11605-022-05455-1.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George Triadafilopoulos.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-08041-w.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Triadafilopoulos, G., Mashimo, H., Tatum, R. et al. Mixed Esophageal Disease (MED): A New Concept. Dig Dis Sci 68, 3542–3554 (2023). https://doi.org/10.1007/s10620-023-08008-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-023-08008-x

Keywords

Navigation